TENAX THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tenax Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Tenax Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $3.96M, a 101% increase year-over-year.
  • Tenax Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $4.84M, a 63.3% decline year-over-year.
  • Tenax Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $7.71M, a 30.2% decline from 2022.
  • Tenax Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $11M.
  • Tenax Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$32.5M, a 230% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.84M $3.96M +$1.99M +101% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $2.85M -$3.58M -$2.47M -223% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 $5.32M -$3.8M -$2.39M -170% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 $7.71M $8.25M -$5.46M -39.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $13.2M $1.97M -$945K -32.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $14.1M -$1.11M +$1.75M +61.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 $12.4M -$1.41M +$1.31M +48.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 $11M $13.7M +$24.5M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$13.5M $2.92M -$882K -23.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$12.6M -$2.86M -$1.14M -66.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$11.4M -$2.72M +$21M +88.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$32.5M -$10.8M -$7.98M -282% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$24.5M $3.8M +$6.02M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$30.5M -$1.72M +$430K +20% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$30.9M -$23.7M -$21.1M -795% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$9.85M -$2.83M +$11.2M +79.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$21M -$2.22M -$4.44M -200% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$16.6M -$2.15M -$3.91M -222% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$12.7M -$2.65M -$4.27M -264% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$8.39M -$14M +$4.74M +25.3% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-16
Q3 2019 -$13.1M $2.22M +$688K +44.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$13.8M $1.76M -$106K -5.68% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$13.7M $1.62M +$424K +35.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$14.1M -$18.7M -$2.4M -14.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$11.7M $1.54M +$302K +24.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$12M $1.87M -$1.12M -37.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$10.9M $1.19M -$2.08M -63.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 -$8.84M -$16.3M +$31.1M +65.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$40M $1.23M -$3.04M -71.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$36.9M $2.99M -$1.66M -35.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$35.3M $3.28M +$8.64M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$43.9M -$47.5M Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $4.27M +$7.19M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $4.64M +$9.39M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$5.36M -$2.42M -82.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q3 2015 -$13.5M -$2.92M +$1.13M +28% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$14.6M -$4.75M -$2.58M -119% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$12M -$2.94M +$7.47M +71.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$19.5M -$2.87M +$483K +14.4% Nov 1, 2014 Jan 31, 2015 10-Q 2015-03-17
Q3 2014 -$20M -$4.05M -$523K -14.8% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-10
Q2 2014 -$19.5M -$2.17M +$73.9K +3.29% May 1, 2014 Jul 31, 2014 10-Q 2015-09-09
Q1 2014 -$19.5M -$10.4M -$8.56M -460% Feb 1, 2014 Apr 30, 2014 10-K 2017-03-16
Q4 2013 -$11M -$3.35M -$938K -38.9% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 -$10M -$3.53M -$1.97M -127% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-15
Q2 2013 -$8.07M -$2.25M +$1.34M +37.4% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 -$9.42M -$1.86M +$756K +28.9% Feb 1, 2013 Apr 30, 2013 10-KT 2016-03-14
Q4 2012 -$10.2M -$2.41M +$4.89M +66.9% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 -$15.1M -$1.56M +$1.37M +46.8% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-17
Q2 2012 -$16.4M -$3.59M -$717K -25% May 1, 2012 Jul 31, 2012 10-Q 2013-09-17
Q1 2012 -$15.7M -$2.61M -$5.46M -192% Feb 1, 2012 Apr 30, 2012 10-K 2013-06-26
Q4 2011 -$10.2M -$7.3M -$9.84M -387% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 -$405K -$2.93M -$4.98M -243% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-14
Q2 2011 $4.58M -$2.87M -$5.87M -196% May 1, 2011 Jul 31, 2011 10-Q 2012-09-19
Q1 2011 $10.4M $2.85M Feb 1, 2011 Apr 30, 2011 10-K 2012-07-25
Q4 2010 $2.54M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-15
Q3 2010 $2.05M Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
Q2 2010 $3M May 1, 2010 Jul 31, 2010 10-Q 2011-09-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.